Bao-Hui Han (Baohui Han, Bo Zhang)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

St Segment Elevation Myocardial Infarction

Top Venues

International journal of cancer

Cancer medicine

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Zheng, Fang Hu, Wei Nie, Jun Lu, Bo Zhang, Jianlin Xu, Shuyuan Wang, Ying Li, Xiaoxuan Zheng, Wei Zhang, Yinchen Shen, Runbo Zhong, Tianqing Chu, Bao-Hui Han, Hua Zhong, Xueyan Zhang
The prognosis and metabolite changes of NSCLC patients receiving first-line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification. Cancer medicine 13 (17) (2024)
Cuicui Zhang, Tianqing Chu, Qiming Wang, Ying Cheng, Yongxiang Zhang, Ruili Wang, Leilei Ma, Chao-Nan Qian, Bao-Hui Han, Kai Li
Enhancement of anti-PD-L1 antibody plus anlotinib efficacy due to downregulation of PD-L1 in the micro-conduit endothelium within the tumor: a randomized double-blind trial. Cancer biology & medicine (2024)
Hua Zhong, Xueyan Zhang, Panwen Tian, Tianqing Chu, Qisen Guo, Xinmin Yu, Zhuang Yu, Yalun Li, Lijuan Chen, Jie Liu, Yan Zhang, Yan Guan, Xun Shi, Jing Wang, Yanqiu Zhao, Bao-Hui Han
Tislelizumab plus chemotherapy for patients with EGFR -mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy. Journal for immunotherapy of cancer 11 (8) (2023)
Lian Yu, Yaohua Hu, Jianlin Xu, Rong Qiao, Hua Zhong, Bao-Hui Han, Jinjing Xia, Runbo Zhong
Multi-target angiogenesis inhibitor combined with PD-1 inhibitors may benefit advanced non-small cell lung cancer patients in late line after failure of EGFR-TKI therapy. International journal of cancer (2023)
Bo Zhang, Hua Zhong, Chunlei Shi, Zhiqiang Gao, Runbo Zhong, Aiqin Gu, Weimin Wang, Tianqing Chu, Liwen Xiong, Wei Zhang, Huimin Wang, Xueyan Zhang, Bao-Hui Han
Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive-stage small-cell lung cancer patients (DURABLE study). The clinical respiratory journal (2023)
Rong Qiao, Siyao Sang, Jiajun Teng, Hua Zhong, Hui Li, Bao-Hui Han
Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case-Control Study. Biomedicines 11 (6) (2023)
Tianqing Chu, Jie Yuan, Jun Lu, Wei Nie, Runbo Zhong, Bao-Hui Han, Wei Zhang, Chunlei Shi, Jialin Qian, Yanwei Zhang, Xueyan Zhang, Jiajun Teng, Zhiqiang Gao, Yuqing Lou, Jiaqi Li, Huiping Qiang, Chao Zhang, Jin Li, Xuefeng Xia, Hua Zhong, Baohui Han
Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy. Clinical and translational medicine 13 (6) (2023)
Ya Chen, Hongyu Liu, Nana Hu, Yanan Wang, Zhengyu Yang, Junqiang Zhang, Bao-Hui Han
Survival benefit of anlotinib in T790M-positive non-small-cell lung cancer patients with acquired osimertinib resistance: A multicenter retrospective study and exploratory in vitro study. Cancer medicine (2023)
Rong Qiao, Siyao Sang, Jiajun Teng, Hua Zhong, Hui Li, Bao-Hui Han
Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case-Control Study. Biomedicines 11 (6) (2023)
Ya Chen, Yanan Wang, Zhengyu Yang, Minjuan Hu, Jun Lu, Yanwei Zhang, Fangfei Qian, Bo Zhang, Shuyuan Wang, Kai Wang, Wei Zhang, Bao-Hui Han
Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study. Thoracic cancer 13 (5) (2022)
Yujing Li, Yanan Wang, Wensheng Zhou, Ya Chen, Yuqing Lou, Fangfei Qian, Jun Lu, Haohua Jiang, Biao Xiang, Yanwei Zhang, Bao-Hui Han, Wei Zhang
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer. Thoracic cancer 13 (19) (2022)
Jun Lu, Wei Zhang, Keke Yu, Lele Zhang, Yuqing Lou, Ping Gu, Wei Nie, Jie Qian, Jun Xu, Huimin Wang, Hua Zhong, Bao-Hui Han
Screening anlotinib responders via blood-based proteomics in non-small cell lung cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (8) (2022)
Wensheng Zhou, Zhi-Chao Liu, Yanan Wang, Yanwei Zhang, Fangfei Qian, Jun Lu, Huimin Wang, Ping Gu, Minjuan Hu, Ya Chen, Zhengyu Yang, Ruiying Zhao, Yuqing Lou, Bao-Hui Han, Wei Zhang
The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 11 (5) (2022)
Yanwei Zhang, Wei Liu, Hongdao Zhang, Beibei Sun, Tianxiang Chen, Minjuan Hu, Haisheng Zhou, Ying Cao, Bao-Hui Han, Ligang Wu
Extracellular vesicle long RNA markers of early-stage lung adenocarcinoma. International journal of cancer (2022)
Lian Yu, Jianlin Xu, Rong Qiao, Bao-Hui Han, Hua Zhong, Runbo Zhong
Efficacy and safety of anlotinib combined with PD-1/PD-L1 inhibitors as second-line and subsequent therapy in advanced small-cell lung cancer. Cancer medicine (2022)
Lei Cheng, Yanan Wang, Lixin Qiu, Yuanyuan Chang, Haijiao Lu, Chenchen Liu, Bo Zhang, Yan Zhou, Hao Bai, Liwen Xiong, Hua Zhong, Wei Nie, Bao-Hui Han
mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers. Journal of translational medicine 20 (1) (2022)
Yinchen Shen, Jun Lu, Fang Hu, Jialin Qian, Xueyan Zhang, Runbo Zhong, Hua Zhong, Tianqing Chu, Bao-Hui Han
Effect and outcomes analysis of anlotinib in non-small cell lung cancer patients with liver metastasis: results from the ALTER 0303 phase 3 randomized clinical trial. Journal of cancer research and clinical oncology (2022)
Wei Nie, Zhi-Jie Wang, Kai Zhang, Bing Li, Yi-Ran Cai, Feng-Cai Wen, Ding Zhang, Yue-Zong Bai, Xue-Yan Zhang, Shu-Yuan Wang, Lei Cheng, Hua Zhong, Li Liu, Jie Wang, Bao-Hui Han
ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors. BMC medicine 20 (1) (2022)
Wei Zhang, Yanwei Zhang, Wensheng Zhou, Fangfei Qian, Minjuan Hu, Ya Chen, Jun Lu, Yuqing Lou, Bao-Hui Han
PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway. Cancer cell international 21 (1) (2021)
Wei Nie, Lu Gan, Xin Wang, Kai Gu, Fang-Fei Qian, Min-Juan Hu, Ding Zhang, Shi-Qing Chen, Jun Lu, Shu-Hui Cao, Jing-Wen Li, Yue Wang, Bo Zhang, Shu-Yuan Wang, Chang-Hui Li, Ping Yang, Mi-Die Xu, Xue-Yan Zhang, Hua Zhong, Bao-Hui Han
Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation. Oncoimmunology 10 (1) (2021)
Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li, Bao-Hui Han
Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial. Cancer biology & medicine (2021)
Mengxia Li, Rong Qiao, Runbo Zhong, Yujie Wei, Jun Wang, Zheng Zhang, Ling Wang, Tian Xu, Yue Wang, Liping Dai, Wanjian Gu, Bao-Hui Han, Rongxi Yang
FYB Methylation in Peripheral Blood as A Potential Marker for the Early-stage Lung Cancer: A Case-control Study in Chinese Population. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2021)
Ya Chen, Shuyuan Wang, Bo Zhang, Yiming Zhao, Lele Zhang, Minjuan Hu, Wei Zhang, Bao-Hui Han
Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis. Targeted oncology 15 (3) (2021)
Yuqing Lou, Jianlin Xu, Yanwei Zhang, Wei Zhang, Xueyan Zhang, Ping Gu, Hua Zhong, Huimin Wang, Jun Lu, Bao-Hui Han
Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis. Cell death & disease 12 (2) (2021)
Jianhua Shi, Guimin Chen, Haitao Wang, Xiuxiu Wang, Bao-Hui Han, Kai Li, Qiming Wang, Li Zhang, Zhehai Wang, Ying Cheng, Jianxing He, Yuan-Kai Shi, Weiqiang Chen, Yi Luo, Lin Wu, Xiuwen Wang, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li, Zhian Liu
Occurrence of hypertension during third-line anlotinib is associated with progression-free survival in patients with squamous cell lung cancer (SCC): A post hoc analysis of the ALTER0303 trial. Thoracic cancer 12 (17) (2021)
Changhui Li, Jia-Qi Zhang, Xiaohua Yang, Cheng Hu, Tianqing Chu, Runbo Zhong, Yinchen Shen, Fang Hu, Feng Pan, Jianlin Xu, Jun Lu, Xiaoxuan Zheng, Hai Zhang, Wei Nie, Bao-Hui Han, Xueyan Zhang
hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527. Cell death & disease 12 (9) (2021)
Qi Liu, Hai Zhang, Bao-Hui Han, Handong Jiang, Kian Fan Chung, Feng Li
Interstitial lung abnormalities: What do we know and how do we manage? Expert review of respiratory medicine 15 (12) (2021)
Minjuan Hu, Yanwei Zhang, Beibei Sun, Yuqing Lou, Xueyan Zhang, Huimin Wang, Chengya Huang, Wei Zhang, Tianqing Chu, Bao-Hui Han
Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma. Journal of cellular and molecular medicine 24 (7) (2020)
Wei Nie, Jie Qian, Mi-Die Xu, Kai Gu, Fang-Fei Qian, Min-Juan Hu, Jun Lu, Lu Gan, Xue-Yan Zhang, Shu-Hui Cao, Jing-Wen Li, Yue Wang, Bo Zhang, Shu-Yuan Wang, Fang Hu, Chang-Hui Li, Hua Zhong, Bao-Hui Han
A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab. Oncoimmunology 9 (1) (2020)
Dongfang Chen, Jianlin Xu, Rong Qiao, Yizhuo Zhao, Tianqing Chu, Bao-Hui Han, Runbo Zhong
Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 (2020)
Ying Cheng, Bao-Hui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Jing Zhu
Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial. Cancer medicine 9 (8) (2020)
Yuqing Lou, Runbo Zhong, Jianlin Xu, Rong Qiao, Jiajun Teng, Yanwei Zhang, Xueyan Zhang, Tianqing Chu, Hua Zhong, Bao-Hui Han
Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation? Thoracic cancer 11 (5) (2020)
Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Lu, Tianqing Chu, Xueyan Zhang, Huimin Wang, Hua Zhong, Wei Zhang, Bao-Hui Han
Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study. Targeted oncology 15 (2) (2020)
Liwen Xiong, Yuqing Lou, Hao Bai, Rong Li, Jinjing Xia, Wentao Fang, Jie Zhang, Han Han-Zhang, Analyn Lizaso, Bing Li, Aiqin Gu, Bao-Hui Han
Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients. The Journal of international medical research 48 (4) (2019)
Shuyuan Wang, Bo Yan, Yanwei Zhang, Jianlin Xu, Rong Qiao, Yu Dong, Bo Zhang, Yiming Zhao, Lele Zhang, Jie Qian, Jun Lu, Ruiying Zhao, Bao-Hui Han
Different characteristics and survival in non-small cell lung cancer patients with primary and acquired EGFR T790M mutation. International journal of cancer 144 (11) (2019)
Jun Lu, Bao-Hui Han
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy. Technology in cancer research & treatment 17 (2019)
Jie Qian, Wei Nie, Jun Lu, Lele Zhang, Yanwei Zhang, Bo Zhang, Shuyuan Wang, Minjuan Hu, Jianlin Xu, Yuqing Lou, Yu Dong, Yanjie Niu, Bo Yan, Runbo Zhong, Wei Zhang, Tianqing Chu, Hua Zhong, Bao-Hui Han
Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies. International journal of cancer 146 (11) (2019)
Jun Lu, Hua Zhong, Jun Wu, Tianqing Chu, Lele Zhang, Hua Li, Qiming Wang, Rong Li, Yizhuo Zhao, Aiqin Gu, Huimin Wang, Chunlei Shi, Liwen Xiong, Xueyan Zhang, Wei Zhang, Yuqing Lou, Bo Yan, Yu Dong, Yanwei Zhang, Baolan Li, Li Zhang, Xiaodong Zhao, Kai Li, Bao-Hui Han
Circulating DNA-Based Sequencing Guided Anlotinib Therapy in Non-Small Cell Lung Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 6 (19) (2019)
Bo Zhang, Shuyuan Wang, Jie Qian, Wenjia Yang, Fangfei Qian, Jun Lu, Yanwei Zhang, Rong Qiao, Bao-Hui Han
Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas. Cancer 124 (11) (2018)
Bao-Hui Han, Bo Jin, Tianqing Chu, Yanjie Niu, Yu Dong, Jianlin Xu, Aiqing Gu, Hua Zhong, Huimin Wang, Xueyan Zhang, Chunlei Shi, Yanwei Zhang, Wei Zhang, Yuqing Lou, Lei Zhu, Jun Pei
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial. International journal of cancer 141 (6) (2017)